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Summary.-The in vivo response of B16 melanoma and Lewis lung carcinoma to
combinations of hyperthermia and graded doses of CCNU or Melphalan was studied.
To obtain dose-response curves and quantitive comparisons of different treatments,
an agar-colony assay was used to measure survival of cells from excised tumours.
For heating experiments, the use of 2 tumours per animal, one heated and one not,
allowed all other factors to be kept constant. When tumours were immersed in a
water-bath at 43°C for 1 h, Thermal Enhancement Ratios (TER) measured from the
slopes of the dose-response curves were up to 1-6 for CCNU and 2-4 for Melphalan.
Direct heat killing of about 1 decade was seen for 1 h at 43°C.
The anaesthetic Saffan also enhanced drug cell kill; the largest Dose Modifying
Factor (2-7) was measured for Melphalan in the Lewis lung tumour.
The duration of heating, and waterbath temperature, both influenced the enhance-
ment of cell killing by CCNU, as did the time of excision of tumours between 0 and
31 h after treatment. There was no difference in effect between 31 and 24 h.
The interaction between heat and CCNU varied if the interval between them was
altered. The maximum effect was found if the heat and drug were given in close
sequence.
THE USE of local hyperthermia in con-
junction with cytotoxic chemotherapy is
an alternative to the more widely reported
combination ofhyperthermia with X-rays,
for tumour treatment.
In vitro, the cytotoxic effects of Adria-
mycin, Bleomycin, actinomycin-D, thio-
tepa, cis-diamminedichloroplatinum and
the nitrosoureas can all be modified by
heating to temperatures in the range
40-43°C (see review by Hahn, 1979).
Published studies on the response of
EMT6 and KHT mouse tumours to treat-
ment in vivo with Bleomycin or BCNU
(reviewed by Marmor, 1979) indicate that
both tumour-cell killing and regrowth
delay are increased when these drugs are
administered during local tumour heating,
using temperatures in the range 41-43°C.
We have examined the response of the
B16 melanoma and Lewis lung carcinoma
to treatment with local hyperthermia in
combination with systemic administration
of the nitrosourea CCNU (1-(2-chloro-
ethyl)-3-cyclohexyl-1-nitrosourea) or the
alkylating agent melphalan (L-phenyl-
alanine mustard). The response of tum-
ours to treatment in vivo was assessed in
vitro by measuring the ability of excised
cells to form colonies in soft agar.
MATERIALS AND METHODS
Mice and tumours.-Male C57BL/Cbi mice
aged 8-10 weeks were used. B16 melanoma
or Lewis lung carcinoma were implanted
into the gastrocnemius muscles of both hind
limbs (i.e. two tumours per mouse) using the
brei technique described by Steel & Adams
(1975). Tumours were treated 10-14 days
after implantation, at an average weight of
0-2-0-4 g, corresponding to leg diameters in
the range 9.5-11-5 mm. The origins of the
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mouse and tumour lines have been described
previously (Steel & Adams, 1975; Stephens
& Peacock, 1977).
Drugs.-CCNU was obtained in 40mg
capsules (National Cancer Institute) and
melphalan was obtained from Burroughs
Wellcome Ltd, Beckenham, Kent, in 100mg
vials. The drugs were prepared for injection
as described by Stephens & Peacock (1977)
and Peacock & Stephens (1978) and admin-
istered via the i.p. route within 10 min of
preparation.
Anaesthetics.-In most of the experiments
described here, mice were anaesthetized with
Saffan (Glaxo Laboratories, Brentford,
Middlesex), a steroid anaesthetic containing
1.2% w/v of the steroids alphaxalone and
alphadolone in the ratio 3 parts to 1.
Its use has been described previously
(Peacock & Stephens, 1978). Mice were
anaesthetized by i.p. injection at a dose of
96 mg/kg 4-5 min before heating. For 1
group of experiments (Fig. 4b) Sagatal
(sodium pentobarbitone, May and Baker
Ltd, Dagenham, Essex) was used instead as
the anaesthetic. This was administered at a
dose of 60 mg/kg, 6-8 min before heating.
Between administration of anaesthetic and
commencement of hyperthermia, anaesthe-
tized mice were maintained with a rectal
temperature of 36-37°C by placing in a
warm-air environment at 35°C.
Heating technique.-Tumours were heated
by immersion in hot water. Before immersion
the overlying fur was closely shaved. After
receiving anaesthetic, each mouse was laid on
a perspex platform with one tumour-bearing
limb protruding through a hole in the surface.
The platform was then positioned on the
water surface so that each heated leg was
immersed to the pelvis, while the rest of the
animal's body remained dry. Humidity in
the vicinity of the mice was reduced by the
gentle circulation of cool, dry air over the
platform with a fan. The temperature of the
water was controlled to+0-05°C and was
measured with a secondary standard mercury-
in-glass thermometer (BSI, Hemel Hemp-
stead, Herts). Intra-tumour temperature
was measured with laboratory-constructed
0-2 mm diameter copper-constantan thermo-
couples connected to an electronic thermo-
meter (Bailey Instruments, Saddle Brook,
NJ, U.S.A.). Thermocouples were implanted
through 25 gauge hypodermic needles which
were then withdrawn from the tumours,
leaving the probes embedded. Rectaltempera-
tures were measured with thermocouple
probes sheathed in 1mm-diameter polythene
tubing. All thermocouples were calibrated
against the secondary standard thermometer.
Preparation of cell suspensions.-After
treatment, tumour-bearing animals were
killed, the tumours excised and cell suspen-
sions prepared as described previously by
Stephens & Peacock (1978) and Stephens et al.
(1978). Each cell' suspension was obtained
from at least 2 pooled tumours from different
mice given the same treatment. Cell viability,
assessed by exclusion of trypan blue, was
found routinely to be >95%. For untreated
tumours of each type, cell yields obtained by
trypsinization were in the range 0 5-1-2 x
108/g.
Soft-agar cell survival.-Clonogenic survival
of tumour cells was measured in vitro by the
soft-agar colony assay first described by
Courtenay (1976) and modified by Stephens
& Peacock (1978) and Stephens et al. (1978).
Viable cells, as defined above, numbering
from 250 to 2x 104 were suspended in a
solution of 0.3% Noble agar in culture
medium and plated into 30 mm Petri
dishes. The total cell number in each dish was
made up to 2 x 104 by the addition oflethally
irradiated cells of the same type (given 200
Gy in vitro). The culture medium used was
Ham's F12 supplemented with 20%; Donor
Calf Serum (Flow Laboratories Ltd, Irvine,
Scotland). The cultures were incubated at
37TC in a water-saturated atmosphere of
90% N2, 5%,h 02 and 5% CO2 for 14-16 days.
For each experimental point, tumour-cell
colonies of >50 cells were scored in at least
3 dishes. Plating efficiency (PE) was the
mean number of colonies per dish divided by
the number of cells plated per dish. Surviving
fraction (SF) was calculated as the PE for
treated tumour cells divided by the PE for
untreated tumour cells. PE's for cells derived
from untreated B16 or Lewis lung tumours
were in the range 40-70%.
To take account of changes in the cell
yield from tumours after treatment, results
were expressed as the Surviving Fraction per
tumour (SF per tumour) calculated as SF x
(relative cell yield per gram) x (relative
tumour weight). Relative cell yield and rela-
tive tumour weight were calculated by
dividing the yield and weight measurements
in treated tumours by the corresponding
values for untreated (control) tumours. The
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FIG. 1. Temperature measurements in a Lewis lung tumour immersed in water at 4300C. (a) Temper-
ature profiles across two orthogonal diameters perpendicular to the heated leg, 45 min after immer-
sion. (b) Core temperatures of unheated and heated tumours, and rectal temperature, all measured
in the same mouse.
relative weight of treated tumours was not
significantly different from 1.0 up to 24 h
after treatment.
RESULTS
Tumour temperature profile
Fig. 1 shows temperatures measured in a
typical tumour-bearing leg after immer-
sion in water at 43 0°C. In Fig. la the
temperatures across 2 orthogonal diam-
eters were determined by drawing thermo-
couple probes through the leg. Leg diam-
eters in the two "scans" were 10-3 mm
(upper) and 10-7 mm (lower diagram). In
this example, the temperature in the
central part of the tumour was 1 2-
1 6'C below the water temperature, even
after 40min immersion. The temperature
of a tumour in the contralateral unheated
limb was also measured, and this, together
with the mouse rectal temperature and
temperature in the heated leg, is shown in
Fig. l(b). The temperature in the heated
tumour reached its maximum after 15 min.
The temperature in the unheated tumour
did not exceed 36 7°C during 45 min
immersion.
Effect of heat alone on cell survival
Fig. 2(a) shows SF, Relative Tumour-
Cell Yield and SF(tumour) in B16
tumours excised 24 h after immersion in
water at 43 0°C for 1 h. Fig. 2(b) gives
similar data for Lewis lung tumours.
Although the SF for cells recovered after
heating is close to 100°0, a substantial
reduction was found in the SF(tumour).
This indicates that cell death is rapid
after hyperthermia. This can be taken into
account when expressing the overall effect
of the treatment on the tumour, as shown
by SF(tumour). The median SF(tumour)
was 0-21 (B16) and 0-125 (Lewis lung).
For unheated tumours removed from mice
whose opposite leg had been heated, the
SF(tumour) was not significantly differ-
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FIG. 2. Cell survival in (a) B16 and (b)
Lewis lung tumours 24 h after immersion
in water at 43 0°C for 1 hi.
ent from 10, showing that the heat
treatment had only a direct local, not a
systemic effect.
Effect of combined heat and drugs on cell
survival
Cell survival was measured in B16
melanoma 24 h after treatment with
graded doses ofCCNU or melphalan, either
alone or in combination with heating by
immersion in water at 430°C for 1 h
immediately after drug injection. The
resulting dose-response curves are shown
in Fig. 3. The upper curve in each diagram
shows cell survival in tumours treated
with the drug alone, administered without
anaesthetic. For CCNU, this curve has a
shoulder followed by an exponential
decrease in cell survival with dose. For
melphalan, the curve is apparently expo-
nential. Inhyperthermia experiments, con-
current cell survival assays were made on
the heated tumour and the contralateral
tumour not immersed in hot water. Both
tumours were thus subjected to the same
drug and anaesthetic dose, and their
treatments differed only in the applica-
tion of heat. The lower pair of curves in
Fig. 3 show the cell survival in such
unheated and heated B16 tumours after
CCNU or melphalan.
Fig. 4 shows the results of similar
experiments in which Lewis lung tumours
were treated with CCNU or melphalan.
All dose-response curves show an exponen-
tial decrease in cell survival with dose.
In Fig. 4(b), data is shown for 2 different
anaesthetics. The triangular symbols show
the cell survival in tumours treated with
melphalan with or without heat but using
the anaesthetic Sagatal (sodium pento-
barbitone) instead of Saffan. There is no
significant difference in data between the
2 anaesthetics.
Table I gives the values of D37, assessed
by least-squares regression, forexponential
parts of the survival curves in Figs 3 & 4.
Table II summarizes the dose modifying
factors (DMF: ratio of D37 values) due to
Saffan anaesthetic and the thermal
enhancement ratios (TER) for the 2
tumours and 2 drugs. The DMF's for
Saffan were calculated from the survival
curves for the drug alone (upper curves)
and the drug+anaesthetic (middle curves).
TER's were calculated from the survival
curves for the drug+anaesthetic (middle
curves) and the drug+anaesthetic+heat
(lower curves). TER was assessed as a
DMF, i.e. a ratio of survival curve slopes.
This method gives values, independent of
cell survival, which are a measure of the
enhancement of drug action on the tum-
ours by heat. TER could also be calculated
as a ratio ofdrug doses to give an isoeffect,
and this method takes into account the
direct cell killing by heat alone (the zero-
drug dose intercept on the lower curves)
and is an assessment of the total effect of
the heat on the drug-treated tumours.
TER values calculated by this method
would therefore be larger. However, the
value of TER determined for an isoeffect
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FIG. 3. Cell survival in B16 melanoma 24 h after treatment with (a) CCNU or (b) melphalan.
Unheated tumours in conscious mice (D); unheated tumours (0) and heated tumours 43°C for 1 h
(0) in Saffan-anaesthetized mice.
TABLE I.-D37 (mg/kg) for the dose-response curves ofFigs. 3 & 4
Drug alone
Drug+Anaes.
Drug+Anaes. +Heat
t Mean + s.e.
TABLE II. Sum
and TER's f
tumours assai
Heat = 430C Th
B16
CCNU
Melphalan
Lewis lung
CCNU
Melphalan
* D37(drug+ar
D37 (drug+anaeZ
B16 melanoma
, A~~~
CCNU MEL
2-50+0 50t 2-05±0-12
2-00+0-08 1-15+0-10
1-45+0-16 0-74+0.21
.mary ofDMF'sfor Saffan
or B16 and Lewis lung
Lewis lung carcinoma
Ak
CCNU
2-75+0-07
1*53+0 07
0 97 + 009
MEL
3-20+ 0-35
1 19 + 0*05
0* 49+ 0 *03
is clearly dependent on the level of cell
survival chosen and increases as the drug
Ved 24 h after treatment. dose is decreased.
aterbath, 1 h The most pronounced effect, both of
Saffan the anaesthetic and the heat, was seen
DMF TER* for melphalan treatment of the Lewis
1*25+0 25t 1*38+0*16 lung carcinoma. For the triple combina-
1 78+0 19 1-55+0-47 tion of melphalan anaesthetic and heat,
1-80+0-09 1.58+0.17 the overall DMF was 6-5 relative to drug
2 69+0*32 2*43 +0*20 treatment in conscious animals (D37 for
naes.) t Mean+s.e melphalan alone/D37 for Melphalan +
s.+heat) - anaesthetic+heat).
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FIG. 4.-Cell survival in Lewis lung carcinoma 24 h after treatment with (a) CCNU or (b) melphalan.
Unheatedl tumours in conscious mice (F]); unheated tumours in mice anaesthetized by Saffan (0)
or Sagatal (A); heated tumours (43°C for 1 h) in mice anaesthetized by Saffan (0) or Sagatal (A).
Effect ofduration ofheating and tenmperattre
on CCNU enhancement
The increase in cell kill by CCNU, due
to concurrent tumour heating, varied with
both the duration of heating and the
temperature of the water bath. This is
shown in Fig. 5. In these experiments,
mice bearing Lewis lung carcinoma were
given a single i.p. dose of 7 5 mg/kg
CCNU immediately after the start of heat
treatment to one tumour-bearing limb.
Although there is considerable scatter in
cell survival after heat treatments in
these experiments, it is clear that cell
survival decreases with an increase in both
heating time and water temperature. By
contrast, in tumours growing in the
opposite limbs, and therefore subject to
the effects ofthe drug and the anaesthetic,
but without direct heating, cell survival
was about the same (1%) over the whole
range of heating times and temperatures
given to the other limb; and similar to the
value without heat treatment (zero-time
point, Fig. 5(a)). The observed effect of
the anaesthetic on the tumour response to
CCNU was therefore independent of any
systemic effects due to local heating.
Time course of cell killing by heat+CCNU
The data in Fig. 6 indicate the cell
survival after excising Lewis lung tum-
ours at varying times after injection of a
single dose of 7-5 mg/kg of CCNU. As in
previous figures, the curves represent
unheated unanaesthetized, anaesthetized
but unheated, and anaesthetized and
heated tumours (43O0°C water immersion,
1 h). The maximum cell-kill was found
3-4 h after treatmentfor all 3 experimental
conditions, and was similar to the value
measured at 24 h, suggesting no repair of
CCNU damage during this time.
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FIG. 5.-Cell survival in Lewis lung carcinoma 24 h after treatment with 7-5 mg/kg CCNU; with and
witlout heating in water at 43 0°C for various times (a) or for 1 h in water at different temperatures
(b). Unheated (0) and heated (0) tumours in Saffan-anaesthetized mice.
Effect of drug scheduling relative to heat
treatment
The interaction of the heat and drug
was investigated by varying the interval
between a ] h heat treatment (43-0°C
water-immersion) and the time of CCNU
administration. Cell survival 24 h after
the drug injection in both heated and
unheated Lewis lung tumours (from the
same animals) is shown in Fig. 7. The
response of the unheated tumours appears
to remain unchanged when the interval
between the anaesthetic and drug injec-
tion varied by up to 2 h. The response of
the tumours to drug +heat, however, is
schedule dependent; the maximum effect
was seen when the drug was administered
within 30 min before the start of heating.
DISCUSSION
We have found the cell yield in heated
tumours to be consistently reduced to
5-20% of the untreated tumour value.
Histological sections of tumours fixed
24 h after heating showed pycnotic and
condensed cell nuclei and cell boundaries
which appeared broken and ill-defined. In
some heat-treated tumour sections there
were small areas of apparently unaffected
tissue. These observations are similar to
those of Overgaard (1978). We conclude
that the observed drop in tumour-cell
yield is mainly due to rapid in situ
degeneration of many cells after heat
treatment. It is clear that this drop in
tumour-cell yield must be taken into
account when using an excision assay to
measure cell survival, to obtain complete
assessment of the killing effect of heat.
The cell kill seen after heat alone in these
experiments was manifest almost entirely
as a reduction in cell yield (Fig. 2).
Our data on cell survival after drug
treatment in the B16 and Lewis lung
tumours agree well with those published
pr.eviously (Stephens & Peacock, 1977;
Peacock & Stephens, 1978). We have
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FIG. 6.-Cell survival in Lewis lung carcin-
oma at various times after CCNU injection
(7 5 mg/kg) combined with heat (43°C
water-immersion, 1 h). Unheated tumours
in conscious mice (A); unheated (0) and
heated (CO) tumours in Saffan-anaesthetized
mice.
shown that heat (43O0°C water immersion,
1 h) increases tumour-cell killing by CCNU
and melphalan, with TER's for slope
ratios (relative to unheated tumours in
the same animals) in the range 1-4-2-4.
We have also seen a similar increased
cytotoxicity in the contralateral unheated
tumours as a result of using either
Saffan or Sagatal anaesthetics. This en-
hanced cell killing appears to be the
result of an interaction between the drug
and anaesthetic, rather than a systemic
effect of locally heating the contralateral
leg, since equal cell killing was found,
whether or not the opposite leg was
heated (Fig. 5). These results extend those
of Peacock & Stephens (1978) who
found enhancement by Saffan of mel-
phalan cell killing in the B16 melanoma.
Clearly, hyperthermia studies involving
chemotherapeutic drugs need to assess
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FIG. 7. Cell survival in Lewis lung carcin-
oma 24 h after CCNU injection (7-5 mg/kg)
and heat treatment (43°C water-immersion,
1 h) separated by up to 2 h. Unheated (0)
and heated (O) tumours in Saffan-anaes-
thetized mice.
carefully the contribution of anaesthetics,
if TER's are not to be over estimated.
This can easily be done if the anaesthetic
is given to animals bearing unheated
tumours.
We cannot completely rule out the
possibility that the thermal enhancement
of cell killing seen in these experiments is
an enhancement of the anaesthetic-drug
interaction rather than the drug action
alone. However, it is clear from Fig. 7
that while the effect of Saffan on CCNU
cell killing remains constant if the anaes-
thetic is given up to 2 h before or after the
drug, the thermal enhancement changes
markedly with the relative timing of the
heat and CCNU treatments. This does
suggest that the heat directly affects the
CCNU action. Furthermore, in another
tumour system, Carcinoma NT, recent
measurements of tumour-regrowth delay
W W w w~~~~~~~~~~~~~~
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have demonstrated no significant effect of
Sagatal on Melphalan-induced delay, sug-
gesting no drug-anaesthetic interaction.
However, a TER of 2 0 was found when
melphalan was combined with local tum-
our heating for 1 h in water at 43 0°C
(M. C. Joiner, unpublished data).
The cytotoxicity of CCNU did vary if
the tumours were excised at different
times up to 32 h after injection, though
there was no change between 32 and 24 h.
This appears to exclude inhibition of
potentially lethal damage (PLD) repair
as a mechanism for thermal enhancement
of drug action. The results reported here
are compatible with either an increase in
drug delivery into the tumour cells or an
increase in reaction rate between the drug
and its target sites, as a result of heating.
Hahn (1979) hasreported thermal enhance-
ment of cell killing by CCNU in vitro
(HAI Chinese hamster cells) and this
suggests that heat interacts with this drug
at a cellular rather than a physiological or
tissue level.
Both CCNU and melphalan contain
alkylating groups. In a study on the inter-
action of heat with the alkylating agent
Thiotepa in vitro, Johnson & Pavelec
(1973) suggested that, below 42°C,
increased cell killing was compatible with
a thermally-induced increase in the rate
of alkylation. This then might also con-
stitute a mechanism for the interaction of
heat with CCNU or melphalan reported
here.
Fig. 1 shows that in tumours immersed
in hot water the temperature is not
uniform, in agreement with Bleehen et al.
(1977), Robinson et al. (1978) and Hill
et al. (1980), all ofwhom have found intra-
tumour temperature variations similar to
those reported here. It is clear that
temperature uniformity must be improved
by the use of better heating methods, if
scatter in results is to be reduced and,
consequently, the mechanisms of inter-
action in vivo between heat and drugs
clarified.
A criticism of temperature measure-
ments is their invasive nature; i.e. a
temperature probe might cause damage
during insertion, so that readings were not
representative of the true values in
undisturbed tissues. Unfortunately, atech-
nique for routine non-invasive therm-
ometry is currently not available, and the
problem is best approached by using very
small probes to minimize tissue disturb-
ance. In this study we have used probes
with a diameter of 02 mm, which is very
small compared to the diameter of the
heated limbs (9.5-11.5 mm). Cetas &
Connor (1978) have also reported that the
use of temperature sensors mounted in
hypodermic needles can lead to measure-
ment errors due to thermal conduction
along the metal sheath, and tnese errors
can be important when using such probes
for measurements in tissues at depths
< 3 mm. We have therefore used only
unsheathed thermocouple probes for the
temperature measurements reported here.
In conclusion, we have demonstrated
significant thermal enhancement of the
cell-killing effects ofCCNU and melphalan
in two experimental tumours. It therefore
appears that the use of mild local hyper-
thermia might be clinically beneficial in
the management of tumours being treated
with these drugs.
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